ZIVO Bioscience Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
16 Oct 24 | BuyUS$99,966 | John Payne | Individual | 6,343 | US$15.76 | |
16 Oct 24 | BuyUS$49,993 | Laith Yaldoo | Individual | 3,133 | US$15.96 | |
22 Aug 24 | BuyUS$261,342 | Christopher Maggiore | Individual | 31,336 | US$8.34 | |
22 Aug 24 | BuyUS$99,997 | Alison Cornell | Individual | 11,990 | US$8.34 | |
26 Jul 24 | BuyUS$16,744 | Christopher Maggiore | Individual | 2,080 | US$8.05 | |
12 Jun 24 | BuyUS$29,999 | Christopher Maggiore | Individual | 3,764 | US$7.97 | |
02 Jan 24 | BuyUS$49,999 | Alison Cornell | Individual | 41,666 | US$1.20 | |
29 Dec 23 | BuyUS$205,000 | Christopher Maggiore | Individual | 157,692 | US$1.30 | |
13 Dec 23 | BuyUS$45,000 | Christopher Maggiore | Individual | 45,000 | US$1.00 |
Insider Trading Volume
Insider Buying: ZIVO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 57,506 | 1.62% |
VC/PE Firms | 530,989 | 15% |
General Public | 1,338,034 | 37.7% |
Individual Insiders | 1,619,806 | 45.7% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 94.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
533,424 | US$10.0m | 0.59% | no data | |||
530,989 | US$10.0m | 0% | no data | |||
498,443 | US$9.4m | 7.19% | no data | |||
257,975 | US$4.8m | 4.87% | no data | |||
198,644 | US$3.7m | 0% | no data | |||
122,024 | US$2.3m | 0% | no data | |||
57,506 | US$1.1m | 0% | 11.42% | |||
7,909 | US$148.5k | 405% | no data | |||
1,387 | US$26.0k | 0% | no data |